Radient Technologies Inc. (TSXV: RTI) ("Radient") announces that, pursuant to its Stock Option Plan, it has granted incentive stock options to certain directors, officers, employees and consultants of the Company to purchase up to an aggregate of 2,676,000 common shares in the capital stock of the Company. The options are exercisable at a price of $0.75 per share, will expire on June 23, 2024, and will vest in sixteen equal parts over the four years after grant.
Appointment of Chief Operating Officer
Radient is pleased to announce the engagement of Mike Cabigon as Chief Operating Officer. “We are pleased to welcome Mike to the management team, and are excited to add an executive leader principally focused on operations, product development, business development, and investor relations.” Mike has been a Director of Radient since 2012.
Radient extracts natural compounds from a range of biological materials using microwave assisted processing ("MAP™"), a patented technology platform which provides superior customer outcomes in terms of ingredient purity, yield, and cost. From its initial 20,000 square foot manufacturing plant in Edmonton, Alberta, Radient serves market leaders in industries that include pharmaceutical, food, beverage, natural health, personal care and biofuel markets. Visit www.radientinc.com for more information.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.